
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1059 | 945 | 1059 | 896 | 1140 | 1773 |
Fund Return | 5.94% | -5.53% | 5.94% | -3.58% | 2.66% | 5.89% |
Place in category | 368 | 579 | 368 | 449 | 387 | 73 |
% in Category | 56 | 83 | 56 | 80 | 79 | 24 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Raiffeisen Pension Invest Futura BI | 4.24B | 2.68 | 0.50 | 1.94 | ||
Raiffeisen Pension Invest Futura Ba | 4.24B | 6.47 | -2.59 | 1.75 | ||
Raiffeisen Pension Invest Futura YA | 1.35B | 4.01 | -2.95 | 0.39 | ||
Raiffeisen Pension Invest Futura YI | 1.35B | 1.47 | -0.70 | 0.46 | ||
Vontobel Fund CH Ethos Equities Swi | 1.07B | 5.16 | -4.88 | 7.37 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.68B | 12.09 | 5.90 | 7.10 | ||
Pictet CH Institutional Swiss EquZD | 2.25B | 10.28 | 3.87 | 7.82 | ||
Pictet CH Institutional Swiss EquiZ | 2.25B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquiI | 2.25B | 8.86 | 2.05 | 8.05 | ||
Pictet CH Institutional Swiss EquiP | 2.25B | 8.84 | 1.85 | 7.84 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 14.13 | 305.80 | +0.89% | |
Novartis | CH0012005267 | 12.71 | 96.35 | -0.60% | |
ABB | CH0012221716 | 5.27 | 48.90 | +1.49% | |
Zurich Insurance Group | CH0011075394 | 4.34 | 602.40 | +0.07% | |
Sika | CH0418792922 | 4.33 | 233.60 | +1.88% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review